CASC
PILL icon

Coppell Advisory Solutions Corp’s Direxion Daily Pharmaceutical & Medical Bull 3X ETF PILL Stock Holding History

Coppell Advisory Solutions Corp’s Portfolio PILL Stock Details PILL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q1 		– Sell
-100
Closed -$897 – 822
2022
Q4 		$897 Buy
+100
New +$962 ﹤0.01% 949

Other funds holding PILL

Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return
TRCT
Tower Research Capital (TRC) New York $3.85B AUM 32.11% 1-Year Est. Return
CG
Cutler Group San Francisco, California $307M AUM 45.11% 1-Year Est. Return

Coppell Advisory Solutions Corp's PILL Position: Q1 2023 in Review

Coppell Advisory Solutions Corp sold out of Direxion Daily Pharmaceutical & Medical Bull 3X ETF (PILL) in Q1 2023, closing a stake of 100 shares — an estimated $897 sold.

Coppell Advisory Solutions Corp first reported a position in PILL in Q4 2022 and held it in 1 quarter. The position peaked at $897 in Q4 2022. 3 funds tracked by Wall St. Rank hold PILL as of Q1 2023.

  • Coppell Advisory Solutions Corp reported no remaining Direxion Daily Pharmaceutical & Medical Bull 3X ETF position as of Q1 2023 after selling out during the quarter.
  • Coppell Advisory Solutions Corp sold 100 Direxion Daily Pharmaceutical & Medical Bull 3X ETF shares in Q1 2023, an estimated $897.
  • Coppell Advisory Solutions Corp first reported a position in Direxion Daily Pharmaceutical & Medical Bull 3X ETF in Q4 2022 and held it in 1 quarter.
  • Coppell Advisory Solutions Corp's Direxion Daily Pharmaceutical & Medical Bull 3X ETF position peaked at $897 in Q4 2022.
  • 3 funds tracked by Wall St. Rank held Direxion Daily Pharmaceutical & Medical Bull 3X ETF as of Q1 2023.

Based on Coppell Advisory Solutions Corp's 13F filing for Q1 2023, filed 10 May 2023.